Definitive radiotherapy for 114 cases of T3N0 glottic carcinoma: Influence of dose-volume parameters on outcome

Radiotherapy and Oncology

Volumn 53, Issue 1, 1999, Pages 15-21

  Wylie, James P ^a   Sen, Mehmet ^b   Swindell, Rick ^a   Sykes, Andrew J ^a   Farrington, William T ^a   Slevin, Nicholas J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Dose; Glottic; Local control; Radiotherapy; Regional control; Volume

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; DOSE RESPONSE; FEMALE; FOLLOW UP; GLOTTIS; HUMAN; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032708451     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00131-0     Document Type: Article

References (35)

1. ICRU 50. Prescribing, recording and reporting photon beam therapy: International Commission on Radiation Units and Measurements. 1993.
2. Ang K.K., Trotti A., Garden A.S. Importance of overall time factor in post-operative radiotherapy. Proceedings of a 4th International Conference on Head and Neck Cancer. 1996;Vol 1.
3. Burke L.S., Greven K.M., McGuirt W.T., Case D., Hoen H.M., Raben M. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;1001-1006.
4. Byers R.M., Wolf P.F., Ballantyne A.J. Rationale for elective modified neck dissection. Head Neck Surg. 10:1988;160-167.
5. Candela F.C., Shah J., Jaques D.P., Shah J.P. Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch. Otolaryngol. Head Neck Surg. 116:1990;432-435.
6. Deore S.M., Supe S.J., Sharma V., Dinshaw K.A. The predictive role of bioeffect dose models in radiation-induced late effects in glottic cancers. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;281-284.
7. DeSanto L.W. T3 glottic cancer: options and consequences of the options. Laryngoscope. 94:1984;1311-1315.
8. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 44:1997;123-136.
9. Foote R.L., Olsen K.D., Buskirk S.J., Stanley R.J., Suman V.J. Laryngectomy alone for T3 glottic cancer. Head Neck. 16:1994;406-412.
10. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62:1989;679-694.
11. Hansen O., Overgaard J., Hansen H.S., et al. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiother. Oncol. 43:1997;47-51.
12. Harwood A.R., Beale F.A., Cummings B.J., Hawkins N.V., Keane T.J., Rider W.D. T3 glottic cancer: an analysis of dose time-volume factors. Int. J. Radiat. Oncol. Biol. Phys. 6:1980;675-680.
13. Jackson S.M., Weir L.M., Hay J.H., Tsang V.H., Durham J.S. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 43:1997;39-46.
14. Kaplan E.C., Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
15. Kessler D.J., Trapp T.K., Calcaterra T.C. The treatment of T3 glottic carcinoma with vertical partial laryngectomy. Arch. Otolaryngol. Head Neck Surg. 113:1987;1196-1199.
16. Kligerman J., Olivatto L.O., Lima R.A., et al. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx. Am. J. Surg. 170:1995;436-439.
17. Maciejewski B., Preuss-Bayer G., Trott K.R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;321-328.
18. Maciejewski B., Skladowski K., Pilecki B., et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother. Oncol. 40:1996;137-145.
19. Mendenhall W.M., Parsons J.T., Mancuso A.A., Pameijer F.J., Stringer S.P., Cassisi N.J. Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J. Clin. Oncol. 15:1997;2394-2402.
20. Mendenhall W.M., Parsons J.T., Million R.R., Fletcher G.H. Tl-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;1267-1273.
21. Meredith A.P., Randall C.J., Shaw H.J. Advanced laryngeal cancer: a management perspective. J. Laryngol. Otol. 101:1987;1046-1054.
22. O'Sullivan B., Mackillop W., Gilbert R. Controversies in the management of laryngeal cancer: results of an international survey of patterns of care. Radiother. Oncol. 31:1994;23-32.
23. Overgaard J., Sand Hansen H., Sapru W. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck: a randomized multicentre study of 5 versus 6 fractions per week-preliminary report from DAHANCA 6 and 7. Radiother. Oncol. 40:1996;S31.
24. Parsons J.T., Mendenhall W.M., Mancuso A.A., Cassisi N.J., Stringer S.P., Million R.R. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck. 11:1989;123-128.
25. Robbins K.T., Medina J.E., Wolfe G.T., Levine P.A., Sessions R.B., Pruet C.W. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch. Otolaryngol. Head Neck Surg. 117:1991;601-605.
26. Simpson D., Robertson A.G., Lamont D. A comparison of radiotherapy and surgery as primary treatment in the management of T3 N0 M0 glottic tumours. J. Laryngol. Otol. 107:1993;912-915.
27. Slevin N.J., Hendry J.H., Roberts S.A., Agren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy (published erratum appears in Radiother. Oncol. 1992;Nov. 25(3):227). Radiother. Oncol. 24:1992;215-220.
28. Slevin N.J., Vasanthan S., Dougal M. Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;23-28.
29. Spanos W.J. Jr, Shukovsky L.J., Fletcher G.H. Time, dose, and tumor volume relationships in irradiation of squamous cell carcinomas of the base of the tongue. Cancer. 37:1976;2591-2599.
30. Taylor J.M., Withers H.R., Mendenhall W.M. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother. Oncol. 17:1990;95-102.
31. Turner S.L., Slevin N.J., Gupta N.K., Swindell R. Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity-evaluation of late morbidity and a watch policy for the clinically negative neck. Radiother. Oncol. 41:1996;21-29.
32. Wang C.C. Wang C.C. Radiation therapy for head and neck neoplasms. 1997;221-225 Wiley-Liss, New York.
33. Withers H.R., Peters L.J., Taylor J.M., et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;549-562.
34. Withers H.R., Taylor J.M., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
35. Wolf G.T., Hong W.K., Fisher S.G., et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. New Eng. J. Med. 324:1991;1685-1690.